These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 26293066)

  • 1. Comparison of Intraoperative Changes in Blood Glucose According to Model for End-stage Liver Disease Score During Living Donor Liver Transplantation.
    Chung HS; Kim ES; Lee C; Park CS
    Transplant Proc; 2015; 47(6):1877-82. PubMed ID: 26293066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High MELD score does not adversely affect outcome of living donor liver transplantation: Experience in 1000 recipients.
    Yadav SK; Saraf N; Saigal S; Choudhary NS; Goja S; Rastogi A; Bhangui P; Soin AS
    Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28497523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative predictors for refractory hyperglycemia during the neohepatic phase of liver transplantation.
    Chung HS; Lee S; Kwon SJ; Park CS
    Transplant Proc; 2014 Dec; 46(10):3474-80. PubMed ID: 25498075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score.
    Al Sebayel M; Abaalkhail F; Hashim A; Al Bahili H; Alabbad S; Shoukdy M; Elsiesy H
    Transplant Proc; 2015 May; 47(4):1211-3. PubMed ID: 26036556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
    Chok KS; Fung JY; Chan AC; Dai WC; Sharr WW; Cheung TT; Chan SC; Lo CM
    Ann Surg; 2017 Jan; 265(1):173-177. PubMed ID: 28009743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of donor factors to post-reperfusion severe hyperglycemia in patients undergoing living donor liver transplantation.
    Chung HS; Kim ES; Rho MC; Park CS
    Ann Transplant; 2015 Jun; 20():303-11. PubMed ID: 26037827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proposal of Muscle-MELD Score, Including Muscularity, for Prediction of Mortality After Living Donor Liver Transplantation.
    Hamaguchi Y; Kaido T; Okumura S; Kobayashi A; Shirai H; Yagi S; Hammad A; Okajima H; Uemoto S
    Transplantation; 2016 Nov; 100(11):2416-2423. PubMed ID: 27495765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival benefit of living-donor liver transplantation in patients with a model for end-stage liver disease over 30 in a region with severe organ shortage: a retrospective cohort study.
    Yim SH; Kim DG; Kang M; Koh HH; Choi MC; Min EK; Lee JG; Kim MS; Joo DJ
    Int J Surg; 2023 Nov; 109(11):3459-3466. PubMed ID: 37565633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of hemi- versus whole liver transplantation in patients from mainland china with high model for end-stage liver disease scores: a matched analysis.
    Kong L; Lv T; Jiang L; Yang J; Yang J
    BMC Surg; 2020 Nov; 20(1):290. PubMed ID: 33218334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left lobe living donor liver transplantation in adults: What is the safety limit?
    Ikegami T; Yoshizumi T; Sakata K; Uchiyama H; Harimoto N; Harada N; Itoh S; Nagatsu A; Soejima Y; Maehara Y
    Liver Transpl; 2016 Dec; 22(12):1666-1675. PubMed ID: 27540888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of Short-Term and Long-Term Outcomes of Living Donor Liver Transplantation for Patients with a High Model for End-Stage Liver Disease Score.
    Matoba D; Noda T; Kobayashi S; Sasaki K; Iwagami Y; Yamada D; Tomimaru Y; Takahashi H; Doki Y; Eguchi H
    Transplant Proc; 2023 May; 55(4):893-897. PubMed ID: 37120341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is Muscle MELD a More Promising Predictor for Mortality After Living Donor Liver Transplantation?
    Badawy A; Kaido T; Hamaguchi Y; Anazawa T; Yagi S; Fukumitsu K; Kamo N; Okajima H; Uemoto S
    Prog Transplant; 2018 Sep; 28(3):213-219. PubMed ID: 29902957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of postoperative Model for End-Stage Liver Disease scoring system for evaluating liver graft function after living donor liver transplantation.
    Toshima T; Ikegami T; Kimura K; Harimoto N; Yamashita Y; Yoshizumi T; Soejima Y; Ikeda T; Shirabe K; Maehara Y
    Transplant Proc; 2014; 46(1):81-6. PubMed ID: 24507030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Different Scoring Systems Based on Both Donor and Recipient Characteristics for Predicting Outcome after Living Donor Liver Transplantation.
    Ma Y; Wang Q; Yang J; Yan L
    PLoS One; 2015; 10(9):e0136604. PubMed ID: 26378786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.
    Jain A; Singhal A; Kashyap R; Safadjou S; Ryan CK; Orloff MS
    Transplantation; 2011 Aug; 92(4):453-60. PubMed ID: 21799468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of Survival Benefits of Living Versus Deceased Donor Liver Transplant in High Model for End-Stage Liver Disease and Hepatorenal Syndrome.
    Wong TC; Fung JY; Pang HH; Leung CK; Li HF; Sin SL; Ma KW; She BW; Dai JW; Chan AC; Cheung TT; Lo CM
    Hepatology; 2021 Jun; 73(6):2441-2454. PubMed ID: 33006772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.
    Hayashi PH; Forman L; Steinberg T; Bak T; Wachs M; Kugelmas M; Everson GT; Kam I; Trotter JF
    Liver Transpl; 2003 Jul; 9(7):737-40. PubMed ID: 12827562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Living donor liver transplantation for post-Kasai biliary atresia: Analysis of pretransplant predictors of outcomes in infants.
    Kitajima T; Sakamoto S; Sasaki K; Uchida H; Narumoto S; Fukuda A; Teramukai S; Uemoto S; Kasahara M
    Liver Transpl; 2017 Sep; 23(9):1199-1209. PubMed ID: 28590589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival Benefit of Living-Donor Liver Transplant.
    Jackson WE; Malamon JS; Kaplan B; Saben JL; Schold JD; Pomposelli JJ; Pomfret EA
    JAMA Surg; 2022 Oct; 157(10):926-932. PubMed ID: 35921119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.